Article · Journal · 2025

FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option

C. Elendu, Tochukwu W. Okahia, George S. Blewusi, Oluwatobi O.M. Meduoye, Emmanuel C. Ogelle, Arube R. Egbo and 14 more

Annals of Medicine and Surgery

• Open access · Gold
• World top 10%
• With a company
• International · 5 countries

Read it10.1097/ms9.0000000000003670